Opioid δ-receptor agonists show promise for treating IBS-like symptoms

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.

FTC challenges patents held by nine big drugmakers, citing unfair competition

Dive Brief: The Federal Trade Commission is challenging patents for 17 drugs marketed by Abbvie, AstraZeneca, GSK and other pharmaceutical companies, claiming Tuesday that the

November 9, 2023

Leo Pharma agrees to acquire Timber Pharmaceuticals

TMB-001 is intended for the treatment of congenital ichthyosis, a rare skin condition. Credit: Kwangmoozaa / Shutterstock.com. Leo Pharma has entered an agreement for the acquisition of

August 22, 2023

NM-6603 by Nucmito for Melanoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.